-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly Liabilities, Current history and growth rate from Q2 2023 to Q4 2024.
- Neuphoria Therapeutics Inc. Liabilities, Current for the quarter ending December 31, 2024 was $2.13M.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)